Therapy News and Research

RSS

Cancer immunotherapy shows long-term promise in lung cancer

New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery -- to the same extent as chemotherapy but without the side-effects of chemotherapy.

26 Apr 2008

Breast cancer subtypes are different diseases

There is a biological distinction between breast cancers that depend on hormones and those that do not, according to research published in PLoS Genetics (Friday).

26 Apr 2008

Newly refined antibody therapy may be potent treatment for autoimmune diseases

An old, fickle therapy for a variety of autoimmune diseases is getting a makeover, thanks to a decade-long investigation by Rockefeller University researchers.

26 Apr 2008

FDA approves Actonel (risedronate sodium) for postmenopausal osteoporosis

The U.S. Food and Drug Administration (FDA) approved a new once-a-month dose (150 mg) of Actonel (risedronate sodium) tablets for the treatment and prevention of postmenopausal osteoporosis. Actonel is approved to reduce the risk of fractures in postmenopausal women with osteoporosis.

24 Apr 2008

Coffee protects some women against breast cancer

Depending on which variant of a certain gene a woman has, a coffee consumption rate of at least two-three cups a day can either reduce the total risk of developing breast cancer or delay the onset of cancer. This is shown in new research from Lund University and Malmo University in Sweden.

24 Apr 2008

Monitoring AIDS treatment by physical symptoms is effective

When millions of HIV-infected people in poor countries began receiving advanced drug therapies, critics worried that patient care would suffer because few high-tech laboratories were available to guide treatments.

24 Apr 2008

Bioartificial kidney speeds recovery, reduces mortality

Another promising clinical trial for the bioartificial kidney is offering researchers even more hope that within the next few years the device will be available to save lives of patients with acute renal failure.

24 Apr 2008

DNA vaccines may offer hope in multiple sclerosis

Authors from the VA North Texas Health Care System Neurology Section and the Department of Neurology at the University of Texas Southwestern Medical Center at Dallas have highlighted the potential benefits for DNA-based vaccine administration in patients with multiple sclerosis (MS).

24 Apr 2008

Pralatrexate for T-cell lymphoma

The fifth leading cause of cancer in the United States, lymphoma is made up of more than 40 rare and highly diverse diseases that target the body's lymphatic system. Lymphomas include both one of the fastest growing cancers -- Burkitt's lymphoma, which can double in size in as little as a day -- and one of the slowest, chronic lymphocytic leukemia (CLL).

24 Apr 2008

Hepatitis C therapy peginterferon alfa-2b shows promise

The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).

24 Apr 2008

New 3-D ultrasound provides clear images of the major arteries within the brain

Using 3-D ultrasound technology they designed, Duke University bioengineers can compensate for the thickness and unevenness of the skull to see in real-time the arteries within the brain that most often clog up and cause strokes.

24 Apr 2008

Interventions for enhancing medication adherence

Patients often do not take the medicines their doctors prescribe, and a new review of existing research suggests that there is no proven way to get them to follow directions for long periods.

24 Apr 2008

Multiple studies demonstrate use of hyperthermia therapy in treating pancreatic cancer

BSD Medical Corporation has began to report highlights from 204 abstracts summarizing presentations at the International Congress on Hyperthermic Oncology (ICHO) conducted this month in Munich, Germany

24 Apr 2008

Tredaptive and Janumet recommended for approval in European Union

Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.

24 Apr 2008

Researchers develop breath-monitoring device to monitor treatment adherence among HIV-positive people

Researchers at the University of Florida and Xhale have developed a breath-monitoring device that can detect whether people living with HIV/AIDS adhere to their treatment regimens, ANI/Thaindian News reports.

23 Apr 2008

Protein HtpG signals healthier teeth and gums

Antibodies present in people with good oral health could become the first tool for dental professionals to assess a patient's probable response to periodontal disease treatments, say researchers at the University of Michigan.

23 Apr 2008

Scientists determine molecular structures of bacterial AlkB protein and its corresponding human protein, ABH2

A team of University of Chicago scientists has shown how two proteins locate and repair damaged genetic material inside cells.

23 Apr 2008

Competency in colonoscopy requires experience with 150 cases or more

Researchers from Korea have found that technically efficient screening and diagnostic colonoscopy generally requires experience with 150 cases or more.

23 Apr 2008

Slowing the spread of cancer in Albania

Once locked in decades of isolation, Albania is seeing new horizons in the fight against poverty. Expectations run high, driving demands for better - and healthier - lives.

23 Apr 2008

ASTRO launches online practice quality improvement project

The American Society for Therapeutic Radiology and Oncology launched its Performance Assessment for the Advancement of Radiation Oncology Treatment (PAAROT) program on April 1 as a way for ASTRO members to satisfy the American Board of Radiology's Maintenance of Certification program requirements.

23 Apr 2008